CAMP Q1 2021 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$125M

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$82M-6.0% YoY

Gross Profit

$35M42.2% margin

Operating Income

-$289,000-0.4% margin

Net Income

-$9M-10.7% margin

EPS (Diluted)

$-0.25

QoQ Revenue Growth

-6.9%

Cash Flow

Operating Cash Flow

$4M

Free Cash Flow

$2M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$434M

Total Liabilities

$339M

Stockholders' Equity

$95M

Cash & Equivalents

$95M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$82M	$87M	-6.0%
Gross Profit	$35M	$33M	+3.8%
Operating Income	-$289,000	-$25M	+98.8%
Net Income	-$9M	-$56M	+84.4%

Revenue Segments

Product

$31M55%

Application Subscriptions And Other Services

$26M45%

Geographic Segments

UNITED STATES

$29M52%

E M E A

$13M23%

South America

$8M14%

Asia Pacific

$4M7%

All Other

$2M3%